Targeted breast cancer treatment approved for routine NHS use
By Liz Wells 11 April 2025
NICE is recommending capivasertib with fulvestrant to treat women with advanced breast cancer, which means the drug will be funded immediately through the Cancer Drugs Fund.
NHS England data reveals record breast screening level
By Liz Wells 18 February 2025
A record number of women are up to date with their breast screening, yet almost a third of invitees did not attend last year, according to NHS figures.
NHS launches first breast screening campaign
By Liz Wells 17 February 2025
The NHS in England has launched its first awareness campaign to highlight the benefits of breast screening and encourage more women to make the most of regular mammograms.
Social Worker
Band G SCP 32-37 (£41,511 - £46,731 per annum)
Sandwell, West MidlandsBand G SCP 32-37 (£41,511 - £46,731 per annum)
Wheelchair Therapist
£37,938 to £40,476, Grade 9.
Wakefield, West Yorkshire£37,938 to £40,476, Grade 9.
Team Co-ordinator
£29,314 - £34,997 per annum
Hybrid working – allocated to offices in Coventry or York£29,314 - £34,997 per annum
Social Worker
Band G SCP 32-37 (£41,511 - £46,731 per annum)
Sandwell, West MidlandsBand G SCP 32-37 (£41,511 - £46,731 per annum)
Wheelchair Therapist
£37,938 to £40,476, Grade 9.
Wakefield, West Yorkshire£37,938 to £40,476, Grade 9.
Team Co-ordinator
£29,314 - £34,997 per annum
Hybrid working – allocated to offices in Coventry or York£29,314 - £34,997 per annum
©2024 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
